Testing effectiveness (Phase 2)Study completedNCT04921904
What this trial is testing
Abemaciclib Plus Ramucirumab for Esophageal/Gastroesophageal Junction Ca
Who this might be right for
Metastatic Esophageal AdenocarcinomaMetastatic Gastroesophageal Junction Adenocarcinoma
Baylor Research Institute 26